Rankings
▼
Calendar
OPRX Q2 2024 Earnings — OptimizeRx Corporation Revenue & Financial Results | Market Cap Arena
OPRX
OptimizeRx Corporation
$128M
Q2 2024 Earnings
Healthcare
Medical - Healthcare Information Services
Income Statement
Revenue
$19M
+36.1% YoY
Gross Profit
$12M
62.2% margin
Operating Income
-$4M
-19.9% margin
Net Income
-$4M
-21.3% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
-4.5%
Cash Flow
Operating Cash Flow
$782,000
Free Cash Flow
$697,000
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$173M
Total Liabilities
$52M
Stockholders' Equity
$121M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$19M
$14M
+36.1%
Gross Profit
$12M
$8M
+49.6%
Operating Income
-$4M
-$5M
+22.7%
Net Income
-$4M
-$4M
+3.7%
← FY 2024
All Quarters
Q3 2024 →